MedTrace Logo

FaibaLite - Reduce Weight, One Bite at a Time

NCT07045766 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2026-04-17

No results posted yet for this study

Summary

This study aims to evaluate the suitability of a fiber-enriched chewing gum as a practical and accessible approach to support healthy body weight management.

Conditions

  • Nutritional and Metabolic Diseases

Interventions

DIETARY_SUPPLEMENT

FibreGum chewing gum

Chewing gum containing galactooligosaccharides (GOS), delivering a total daily dose of 3 g of dietary fiber.

Sponsors & Collaborators

  • DCB Research AG

    collaborator OTHER

  • University of Bern

    lead OTHER

Principal Investigators

  • Maria L Balmer, Prof. med. · Department of Biomedical Research, University of Bern

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-01
Primary Completion
2026-02-28
Completion
2026-04-13

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07045766 on ClinicalTrials.gov